FDA OKs Accurian Nerve Ablation Platform for Chronic Pain FDA OKs Accurian Nerve Ablation Platform for Chronic Pain

The minimally invasive ablative procedure destroys small areas of nerve tissue to stop it from sending pain signals, thereby reducing pain, Medtronic says.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news